October 29, 2020

Proteinase K Market Size & Growth

According to a new market research report published by Global Market Estimates, the Global Proteinase K Market is expected to grow at a CAGR of 8.05% during the forecast period (2020-2026).

Healthcare evolution and government expenditure in R & D techniques are giving a positive trajectory to the growth of the proteinase k market. Extended support from local and multinational players in the adoption and discovery of a new variety of products offering is creating significant demand for proteinase k on a positive note. Low cost of production, specificity, and excellent stability has uplifted the proteinase k popularity in the last few years.

The efficient detection of COVID-19 with the help of proteinase K pre-treatment activity has boosted the demand for the product in many severely affected regions. Brazil recently comes up with a discovery of COVID-19 testing without the involvement of the RNA extraction step as it requires skilled workers with sufficient funding. The new protocol involves proteinase K during sample pre-treatment thus discarding all the time and cost-consuming protocols.

Browse 125 Market Data Tables and 107 Figures spread through 183 Pages on "Global Proteinase K Market - Forecasts to 2026" https://www.globalmarketestimates.com/market-report/global-proteinase-k-market-2406

By Type of Therapeutic Area (Infectious diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Neurology, and Other therapeutic areas); By Form (Powder, and Liquid); By Region (North America, Europe, Asia Pacific, MEA, and CSA), Company Market Share & Competitor Analysis

Key Market Insights:

·         The Global Proteinase K Marketis expected grow with a CAGR value of 8.05% during 2020-2026

·         Infectious diseases accounted for the largest revenue of the proteinase K market. Wide clinical relevance and application of proteinase K in the detection of countless infectious diseases are building the demand for the product in this region.

·         The powder segment builds the highest proteinase K market in the year 2019 owing to notable advantages compared to the liquid segment

·         Asia Pacific is anticipated to grow the proteinase K market at the fastest CAGR% between the 2020-2026 period

Key global players in the Global Proteinase K Marketinclude: Merck KGaA, Codexis, F. Hoffmann-La Roche Ltd., Amano Enzymes, Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Amicogen, Dyadic International, BBI Solutions, Affymetrix, and American Laboratories among others.

.

Browse the Global Proteinase K MarketReport @: https://www.globalmarketestimates.com/market-report/global-proteinase-k-market-2406

·         Therapeutic Area Outlook (Revenue, USD Billion, 2020 - 2026)

·         Infectious diseases

·         Diabetes

·         Oncology

·         Cardiology

·         Nephrology

·         Autoimmune diseases

·         Neurology

·         Other therapeutic areas

·         Form Outlook (Revenue, USD Billion, 2020 - 2026)

·         Powder

·         Liquid

·         Regional Outlook (Revenue, USD Billion, 2020 - 2026)

·         North America

·         U.S.

·         Canada

·         Mexico

·         Europe

·         Germany

·         UK

·         France

·         Spain

·         Italy

·         Rest of Europe

·         Asia Pacific

·         China

·         India

·         Japan

·         South Korea

·         Australia

·         Rest of APAC

·         Central & South America

·         Brazil

·         Argentina

·         Chile

·         Rest of CSA

·         Middle East & Africa

·         Saudi Arabia

·         South Africa

·         UAE

·         Rest of MEA

Contact: Yash Jain

Email address: [email protected]

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php